Literature DB >> 8485709

Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.

C A Stein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8485709

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  44 in total

1.  Suramin inhibits the in vitro expression of encephalitis B virus proteins NS3 and E.

Authors:  Keshu Xu; Hongyu Ren; Jianwen Zhu; Yun Yang; Fang Liao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

2.  Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.

Authors:  Maryam B Lustberg; Shubham Pant; Amy S Ruppert; Tong Shen; Yong Wei; Ling Chen; Lisa Brenner; Donna Shiels; Rhonda R Jensen; Michael Berger; Ewa Mrozek; Bhuvaneswari Ramaswamy; Michael Grever; Jessie L Au; M Guillaume Wientjes; Charles L Shapiro
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-22       Impact factor: 3.333

3.  Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.

Authors:  J Mateo; M T Miras-Portugal; E Castro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

5.  Suramin enhances ethanol-induced injury to gastric mucosa in rats.

Authors:  C Blandizzi; G Gherardi; C Marveggio; G Lazzeri; G Natale; D Carignani; R Colucci; M Del Tacca
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

6.  Directed molecular screening for RecA ATPase inhibitors.

Authors:  Tim J Wigle; Scott F Singleton
Journal:  Bioorg Med Chem Lett       Date:  2007-04-10       Impact factor: 2.823

Review 7.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

8.  Suramin inhibits renal fibrosis in chronic kidney disease.

Authors:  Na Liu; Evelyn Tolbert; Maoyin Pang; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

Review 9.  Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

Authors:  S B Noonberg; C C Benz
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

10.  Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc.

Authors:  W Chen; J L Martindale; N J Holbrook; Y Liu
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.